Peter Blume-Jensen
President and CEO, Director · Acrivon Therapeutics, Inc.
- 2024
- Aug 27, 2026
- 16
Summary
Latest filing:
Peter Blume-Jensen is President and CEO, Director of Acrivon Therapeutics, Inc. (ACRV). 16 SEC Form 4 filings on record going back to 2024, most recently on 27 August 2026. Most recent open-market trade: sold $31K of ACRV on 27 August 2026. Lifetime open-market purchases: $82K. Lifetime open-market sales: $34K.
Recent transactions
20The latest 20 SEC Form 4 transactions reported by Peter Blume-Jensen.
Trading pattern
InsiderAlpha's records for Peter Blume-Jensen go back to 2024: 16 primary Form 4 filings, an average of 5.3 per year. The typical open-market purchase is $82K (1 buy totaling $82K). The largest single buy on record is $82K of ACRV in 2026. Sales side: 3 recorded sales totaling $34K, so the filing history runs buy-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter Blume-Jensen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric Devroe - $18K in ACRV purchases and sales in the last 12 months
- Adam D. Levy - $17K in ACRV purchases and sales in the last 12 months
- Mary Miller - $2K in ACRV purchases and sales in the last 12 months
- Erick Gamelin - $804 in ACRV purchases and sales in the last 12 months
- Katharine Peterson - $203 in ACRV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter Blume-Jensen?
Peter Blume-Jensen is a corporate insider, tracked as President and CEO, Director of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter Blume-Jensen submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Peter Blume-Jensen been buying or selling stock?
Recorded transactions: 1 open-market purchase ($82K) and 3 open-market sales ($34K) across all tracked filings.